Evidence map›Paper›PMID 40841990›Full record

ArticleClinical genetics2026

Missense Variants in the Second Transmembrane Domain of TMEM17 Disrupt Its Stability and Function and Lead to a Wide Phenotypic Spectrum of Ciliopathies.

Lucile Boutaud, Chunmei Li, Candice Moncler, Laure Verlin, Meriem Garfa-Traoré, Nicolas Bourgon, Dhruvin Akbari, Jeanne Porée, Valentina Serpieri, Marine Panza and 10 more

Abstract read
In one paragraph

Article in Clinical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lucile BoutaudINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.
Chunmei LiDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Candice MonclerINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.
Laure VerlinINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.
Meriem Garfa-TraoréCell Imaging Platform, INSERM-US24-CNRS UMS 3633 Structure Fédérative de Recherche Necker, Paris University, Paris, France.
Nicolas BourgonService de Médecine Génomique des Maladies Rares, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Dhruvin AkbariDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Jeanne PoréeINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.
Valentina SerpieriDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Marine PanzaCell Imaging Platform, INSERM-US24-CNRS UMS 3633 Structure Fédérative de Recherche Necker, Paris University, Paris, France.
Lynda HaddadService de Médecine Génomique des Maladies Rares, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
Patrick NitschkéImagine Institute, Bioinformatics Platform, INSERM UMR 1163, Université de Paris, Paris, France.
Jacqueline AzizaDépartement de Pathologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
Cristina MattSeccion de Genética Médica del Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno", CP (C1431FWO), Buenos Aires, Argentina.
Enza Maria ValenteDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Patricia GargalloSeccion de Genética Médica del Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno", CP (C1431FWO), Buenos Aires, Argentina.
Charlotte DubucsDépartement de Pathologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
Tania Attié-BitachINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.ORCID 0000-0002-1155-3626
Michel R LerouxDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
Sophie ThomasINSERM UMR 1163, Institut Imagine, Université Paris Cité, Paris, France.

Funding

Agence Nationale de la Recherche ANR-10-IAHU-01Agence Nationale de la Recherche ANR-17-CE16-0003-01,ANR-17-RHUS-0002CIHR MOP-142243CIHR PJT-156042Michael Smith Foundation for Health ResearchTelethon Foundation Italy GGP20070
6 · The paper itself

Abstract

Ciliopathies are rare genetic disorders characterized by significant genetic and phenotypic variability. Over 140 proteins localized to primary cilia, which are sensory organelles essential for vertebrate development, are implicated. TMEM17 encodes a transmembrane protein at the ciliary transition zone and was previously proposed as a potential ciliopathy gene, based on reports of individuals from two families with orofaciodigital syndrome type 6 (OFD6) and Joubert syndrome (JS). Here, we report two unrelated fetuses with occipital encephalocele, polydactyly, and kidney cysts, in whom exome sequencing identified a founder homozygous missense variant (Arg94Trp) in TMEM17, affecting a highly conserved residue. This expands the TMEM17-associated phenotypic spectrum to include Meckel syndrome (MKS). Comprehensive functional analyses of all known TMEM17 variants, using patient tissues/cells and a C. elegans model system, demonstrate a loss-of-function mechanism. Our study reveals severe functional consequences, including TMEM17 destabilization and mislocalization, anomalies in cilium composition and function, and abrogation of Sonic Hedgehog signaling. These experiments confirm the pathogenicity of all TMEM17 variants and underscore its essential role at the ciliary transition zone. Collectively, our findings establish TMEM17 as a bona fide ciliopathy gene, associated with a wide phenotypic spectrum ranging from viable syndromes (OFD6 and JS) to a fetal-lethal condition (MKS).

Indexed as

CiliopathiesMembrane ProteinsMutation, MissenseAbnormalities, MultipleAnimalsCaenorhabditis elegansCerebellumCiliaCiliary Motility DisordersEncephaloceleExome SequencingEye AbnormalitiesFemaleHumansKidney Diseases, CysticMaleMembrane ProteinsciliopathyJoubert syndromeMeckel syndromeOro‐Facio‐digital syndromeprimary ciliumTMEM17transition zone

Identifiers

PMID40841990
PMCPMC12779253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.